United States

People: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

8 Dec 2016
Change (% chg)

$0.01 (+0.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bokkelen, Gil 

Dr. Gil Van Bokkelen, Ph.D., is Chairman of the Board, Chief Executive Officer of Athersys Inc. Dr. Van Bokkelen co-founded Athersys, Inc. in 1995 and served as Chief Executive Officer and Director since the Company’s founding. Prior to May 2006, he also served as the Company’s President. Dr. Van Bokkelen served as the Chairman of the Alliance for Regenerative Medicine from 2010 through 2012, a Washington D.C. based consortium of companies, patient advocacy groups, disease foundations, and clinical and research institutions that are committed to the advancement of the field of regenerative medicine, and now serves ex officio. He is also the Chairman of the Board of Governors for the National Center for Regenerative Medicine, and has served on a number of other boards, including the Biotechnology Industry Organization’s ECS board of directors (from 2001 to 2004, and from 2008 to present). He holds his Ph.D. in Genetics from Stanford University, his B.A. in Economics from the University of California at Berkeley, and his B.A. in Molecular Biology from the University of California at Berkeley.

Basic Compensation

Total Annual Compensation, USD 599,815
Restricted Stock Awards, USD 152,328
Long-Term Incentive Plans, USD --
All Other, USD 308,871
Fiscal Year Total, USD 1,061,010

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gil Bokkelen


William Lehmann


John Harrington


Robert Deans


Laura Campbell


Lee Babiss

As Of  30 Dec 2014